Optical coherence tomography: From research to clinical application

Minerva Medica

Volumn 103, Issue 6, 2012, Pages 441-464

  Alfonso, F ^a   Sandoval, J ^a   Cardenas A ^a   Medina, M ^a   Cuevas, C ^a   Gonzalo, N ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Coronary restenosis; Plaque, atherosclerotic; Stents; Thrombosis; Tomography, optical coherence

Indexed keywords

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY ANEURYSM; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; OPTICAL COHERENCE TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; STENT THROMBOSIS;

CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY VESSELS; HUMANS; TOMOGRAPHY, OPTICAL COHERENCE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84875292461     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Lowe HC, Narula J, Fujimoto JG, Jang IK. Intracoronary optical diagnostics. Current status, limitations and potential. J Am Coll Cardiovasc Interv 2011;4:1257-70.
2. Ferrante G, Presbitero P, Whitbourn R, Barlis P. Current applications of optical coherence tomography for coronary intervention. In J Cardiol 2012 [Epub ahead of print].
3. Prati F, Guagliumi G, Mintz GS, Costa M, Regar E, Akasaka T et al. for the Expert's OCT Review Document. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J 2012 [Epub ahead of print].
4. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG et al. International Working Group for Intravascular Optical Coherence Tomography (IWG-IVOCT). Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012;59:1058-72.
5. Regar E, van Soest G, Bruining N, Constantinescu AA, van Geuns RJ, van der Giessen W et al. Optical coherence tomography in patients with acute coronary syndrome. EuroIntervention 2010;6(Suppl G):G154-60.
6. Gonzalo N, Escaned J, Alfonso F, Jiménez-Quevedo P, Zakhem B, Bañuelos C et al. Is refined OCT guidance of stent implantation needed? EuroIntervention 2010;6(Suppl G):G145-53.
7. Herrero-Garibi J, Cruz-Gonzalez I, Parejo-Diaz P, Jang IK. Optical coherence tomography: Its value in intravascular diagnosis today. Rev Esp Cardiol 2010;63:951-62.
8. Maehara A, Mintz GS, Weissman NJ. Advances in intravascular imaging. Circ Cardiovasc Intervent 2009;2:482-90.
9. Suh WM, Seto AH, Margey RJP, Cruz-Gonzalez I, Jang IK. Intravascular detection of the vulnerable plaque. Cir Cardiovasc Imaging 2011;4:169-78.
10. Suter MJ, Nadkarni SK, Weisz G, Tanaka A, Jaffer FA, Bouma BE et al. Intravascular optical imaging technology for investigating the coronary artery. J Am Coll Cardiol 2011;4:1022-39.
11. Gutierrez-Chico JL, Alegría-Barrero A, Teijeiro-Mestre R, Chan PH, Tsujioka H, de Silva R et al. Optical coherence tomography: From research to practice. Eur Heart J Cardiovasc Imaging 2012;13:370-84.
12. Prati F, Cera M, Ramazzotti V, Imola F, Giudice R, Albertucci M. Safety and feasibility of a new non-occlusive technique for facilitated intracoronary optical coherence tomography (OCT) acquisition in various clinical and anatomical scenarios. EuroIntervention 2007;3:365-70.
13. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640-5.
14. Kume T, Akasaka T, Kawamoto T, Ogasawara Y, Watanabe N, Toyota E et al. Assessment of coronary arterial thrombus by optical coherence tomography. AmJ Cardiol 2006;97:1713-7. (Pubitemid 43817856)
15. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Kataiwa H et al. Distribution and frequency of thincapped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography. Am J Cardiol 2008;102:975-9.
16. Kume T, Akasaka T, Kawamoto T, Okura H, Watanabe N, Toyota E et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 2006;152:755. e1-4.
17. Tearney GJ, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf KH et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003;107:113-9. (Pubitemid 36070942)
18. Jang IK, Bouma BE, Rang DH, Park SJ, Park SW, Seung KB et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: Comparison with intravascular ultrasound. J Am Coll Cardiol 2002;39:604-9. (Pubitemid 34158155)
19. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005;111:1551-5. (Pubitemid 40470652)
20. Sawada T, Shite J, García-García HM, Shinke T, Watanabe S, Otake H et al. Feasibility of combined used of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for the detection of thin-cap fibroatheroma. Eur Heart J 2008;29;1136-46. (Pubitemid 351844891)
21. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933-9. (Pubitemid 47313602)
22. Yonetsu T, Kakuta T, Lee T, Takahashi K, Kawaguchi N, Yamamoto G et al. In vivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomography. Eur Heart J 2011;32:1251-9.
23. Toutouzas K, Karanasos A, Tsiamis E, Riga M, Drakopoulou M, Synetos A et al. New insights by optical coherence tomography into the differences and similarities of culprit ruptured plaque morphology in non-ST-elevation myocardial infarction and ST-elevation myocardial infarction. Am Heart J 2011;161:1192-9.
24. Ino Y, Kubo T, Tanaka A, Kuroi A, Tsujioka H, Ikejima H et al. Difference of culprit lesion morphologies between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. JACC Cardiovasc Interv 2011;4:76-82.
25. Alfonso F, Virmani R. New morphological insights on coronary plaque rupture: bridging the gap from anatomy to clinical presentation? JACC Cardiovasc Interv 2011;4:83-6.
26. MacNeill BD, Jang IK, Bouma BE, Iftimia N, Takano M, Yabushita H et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004;44:972-9. (Pubitemid 39165129)
27. Chia S, Raffel OC, Takano M, Tearney GJ, Bouma BE, Jang IK. Comparison of coronary plaque characteristics between diabetic and non-diabetic subjects: An in vivo optical coherence tomography study. Diabetes Res Clin Pract 2008;81:155-60.
28. Ferrante G, Nakano M, Prati F, Niccoli G, Mallus MT, Ramazzotti V et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinico-pathological study. Circulation 2010;122:2505-13
29. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Tanimoto T et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. Eur Heart J 2009;30:1348-55.
30. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Tanimoto T et al. Morphology of exertion-triggered plaque rupture in patients with acute coronary syndrome: an optical coherence tomography study. Circulation 2008;118:2368-73
31. Takarada S, Imanishi T, Kubo T, Tanimoto T, Kitabata H, Nakamura N et al. Effect of statin therapy on coronary fibrous cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. Atherosclerosis 2009;202;491:7.
32. Hattori K, Ozaki Y, Ismail TF, Okumura M, Naruse H, Kan S et al. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging 2012;5:169-77.
33. Alfonso F. Spontaneous coronary artery dissection: new insights from the tip of the iceberg? Circulation 2012;126:667-70
34. Alfonso F, Paulo M, Gonzalo N, Dutary J, Jimenez-Quevedo P, Lennie V et al. Diagnosis of spontaneous coronary artery dissection by optical coherence tomography. J Am Coll Cardiol 2012;59:1073-9.
35. Alfonso F, Nuñez-Gil I, Hernandez R. Optical coherence tomography findings in tako-tsubo cardiomyopathy. Circulation 2012;126:1663-4.
36. Gonzalo N, Serruys PW, García-García H, van Soest G, Okamura T, Ligthart J et al. Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultraound in human coronary arteries. Rev Esp Cardiol 2009;62:615-24.
37. Gonzalo N, Escaned J, Alfonso F, Nolte C, Rodriguez V, Jimenez-Quevedo P et al. Morphometry assessment of coronary stenosis relevance with optical coherence tomography: a comparison with fractional flow reserve and intravascular ultrasound. J Am Coll Cardiol 2012;59:1080-9.
38. Stefano GT, Bezerra HG, Attizzani G, Chamié D, Mehanna E, Yamamoto H et al. Utilization of frequency domain optical coherence tomography and fractional flow reserve to assess intermediate coronary artery stenoses: conciliating anatomic and physiologic information. Int J Cardiovasc Imaging 2011;27:299-308.
39. van Soest G, Regar E, Goderie TP, Gonzalo N, Koljenović S, van Leenders GJ et al. Pitfalls in plaque characterization by OCT: image artifacts in native coronary arteries. JACC Cardiovasc Imaging 2011;4:810-3.
40. Secco GG, Foin N, Viceconte N, Borgia F, De Luca G, Di Mario C. Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons. EuroIntervention 2011;7:828-34.
41. Gonzalo N, Serruys PW, Okamura T, Shen ZJ, Onuma Y, Garcia-Garcia HM et al. Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach. Heart 2009;95:1913-9.
42. Tahara S, Bezerra HG, Sirbu V, Kyono H, Musumeci G, Rosenthal N et al. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial. Heart 2010;96:1574-8.
43. Guagliumi G, Costa MA, Sirbu V, Musumeci G, Bezerra HG, Suzuki N et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Circulation 2011;123:274-81.
44. Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligthart J et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. JACC Cardiovasc Interv 2009;2:445-52.
45. Gutiérrez-Chico JL, Regar E, Nüesch E, Okamura T, Wykrzykowska J, di Mario C et al. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography. Circulation 2011;124:612-23.
46. Gutiérrez-Chico JL, Wykrzykowska J, Nüesch E, van Geuns RJ, Koch KT, Koolen JJ et al. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Circ Cardiovasc Interv 2012;5:20-9.
47. Futamatsu H, Sabaté M, Angiohllo DJ, Jimenez-Quevedo P, Corros C, Morikawa-Futamatsu K et al. Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study. J Am Coll Cardiol 2006;48:1139-45. (Pubitemid 44345135)
48. Prati F, Stazi F, Dutary J, La Manna A, Di Giorgio A, Pawlosky T et al. Detection of very early stent healing after primary angioplasty: an optical coherence tomographic observational study of chromium cobaltum and first-generation drug-eluting stents. The DETECTIVE study. Heart 2011,97:1841-6.
49. Xie Y, Takano M, Murakami D, Yamamoto M, Okamatsu K, Inami S et al. Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation. Am J Cardiol 2008;102:27-31.
50. Takano M, Yamamoto M, Inami S, Murakami D, Seimiya K, Ohba T et al. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist? J Am Coll Cardiol 2008;51:968-9. (Pubitemid 351282461)
51. Radu M, Jørgensen E, Kelbæk H, Helqvist S, Skovgaard L, Saunamäki K. Optical coherence tomography at follow-up after percutaneous coronary intervention: relationship between procedural dissections, stent strut malapposition and stent healing. EuroIntervention 2011;7:353-61.
52. Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn AV et al. Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc Imaging 2012;5:71-82.
53. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009;373.897-910.
54. Lee CW, Kang SJ, Park DW, Lee SH, Kim YH, Kim JJ et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 2010;55:1936-42.
55. Kang SJ, Mintz GS, Park DW, Lee SW, Kim YH, Lee CW et al. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. Am J Cardiol 2010;106:1561-5
56. Tanimoto S, Aoki J, Serruys PW, Regar E. Paclitaxel-eluting stent restenosis shows three-layer appearance by optical coherence tomography. EuroIntervention 2006;1:484.
57. Fujii K, Masutani M, Ohyanagi M. Contribution of organized thrombus to in-stent restenosis after sirolimus-eluting stent implantation: optical coherence tomography findings. Eur Heart J 2008;29:1385. (Pubitemid 351806473)
58. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009;158:284-93.
59. Hou J, Qi H, Zhang M, Ma L, Liu H, Han Z et al. Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis? An optical coherence tomography study. Heart 2010;96:1187-90.
60. Lee SJ, Kim BK, Kim JS, Ko YG, Choi D, Jang Y et al. Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study. Clin Cardiol 2011;34.633-9.
61. Kim BK, Kim JS, Shin DH, Ko YG, Choi D, Jang Y et al. Optical coherence tomography evaluation of in-stent restenotic lesions with visible microvessels. J Invasive Cardiol 2012;24:116-20
62. Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 2011;123:2954-63.
63. Habara M, Terashima M, Nasu K, Kaneda H, Inoue K, Ito T et al. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study. Circ Cardiovasc Interv 2011;4:232-8.
64. Yonetsu T, Kato K, Kim SJ, Xing L, Jia H, McNulty I et al. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging 2012;5:660-6.
65. Alfonso F. Calcified in-stent restenosis: a rare cause of dilation failure requiring rotational atherectomy. Circ Cardiovasc Interv 2012;5;e1-e2.
66. Alfonso F, Fernández-Viña F, Medina M, Hernandez R. Neoatherosclerosis: the missing link between very late stent thrombosis and very late in-stent restenosis. J Am Coll Cardiol 2012 [In press].
67. Sandoval J, Medina M, Alfonso F. Neointimal tissue healing patterns after paclitaxel-eluting balloon tretament of in-stent restenosis: optical coherence tomography and intravascular ultrasound insights. J Invas Cardiol 2012 [In press].
68. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011;57:1314-22.
69. Alfonso F, Sandoval J. New insights on stent thrombosis: in praise of large nationwide registries for rare cardiovascular events. JACC Cardiovasc Interv 2012;5:141-4.
70. Alfonso F, Suárez A, Angtolillo DJ, Sabaté M, Escaned J, Moreno R et al. Findings of intravascular ultrasound during acute stent thrombosis. Heart 2004;90:1455-9. (Pubitemid 39626325)
71. Alfonso F, Suárez A, Pérez-Vizcayno MJ, Moreno R, Escaned J, Bañuelos C et al. Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol 2007;50:2095-7. (Pubitemid 350087569)
72. Degertekin M, Serruys PW, Tanabe K, Lee CH, Sousa JE, Colombo A et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation 2003;108:2747-50. (Pubitemid 37498975)
73. Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W et al. TAXUS II Study Group. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents. Insights from the randomized TAXUS II trial. Circulation 2005;111:900-5. (Pubitemid 40279892)
74. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-34. (Pubitemid 46717965)
75. Siqueira DA, Abizaib AA, Costa JR, Feres F, Mattos LA, Staico R et al. Late incomplete apposition after drugeluting stent: incidence and potential for adverse clinical outcomes. Eur Heart J 2007;28:1304-409.
76. Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi-Zoccai G, Ikejima H et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv 2012;5:12-20.
77. Alfonso F, Dutary J, Paulo M, Gonzalo N, Pérez-Vizcayno MJ, Jiménez-Quevedo P et al. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis. Heart 2012;98:1213-20.
78. Alfonso F, Gonzalo N, Sandoval J. Late drug-eluting stent thrombosis: optical coherence tomography and intravascular ultrasound insights. Circ Cardiovasc Interv 2012;5:615-6.
79. Zakhem B, Fernandez-Ortiz A, Alfonso F. Optical coherence tomography findings during "evolving" stent thrombosis. J Invasive Cardiol 2011;23:E222-5.
80. Alfonso F, Gonzalo N, Hernández R. A rare cause of late drug-eluting stent thrombosis unraveled by optical coherence tomography. Circ Cardiovasc Interv 2011;4:399-400.
81. Alfonso F, Perez-Vizcayno MJ, Ruiz M, Suárez A, Cazares M, Hernández R et al. Coronary Aneurysms After Drug Eluting Stent Implantation: Clinical, Angiographic and Intravascular Ultrasound Findings. J Am Coll Cardiol 2009;53:2053-60.
82. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC et al. Pathological correlates of late drugeluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41. (Pubitemid 46717966)
83. Farooq V, Okamura T, Gogas BD, Heo JH, Magro M, Gomez-Lara J et al. 3D reconstructions of optical frequency domain imaging to improve understanding of conventional PCL JACC Cardiovasc Imaging 2011;4:1044-6.
84. Ughi GJ, Adriaenssens T, Larsson M, Dubois C, Sinnaeve PR, Coosemans M et al. Automatic three-dimensional registration of intravascular optical coherence tomography images. J Biomed Opt 2012;17:026005.
85. Li BH, Leung AS, Soong A, Munding CE, Lee H, Thind AS et al. Hybrid intravascular ultrasound and optical coherence tomography catheter for imaging of coronary atherosclerosis. Catheter Cardiovasc Interv 2012 [Epub ahead of print].
86. Munce NR, Yang VX, Standish BA, Qiang B, Butany J, Courtney BK et al. Ex vivo imaging of chronic total occlusions using forward-looking optical coherence tomography. Lasers Surg Med 2007;39:28-35. (Pubitemid 46239797)
87. Jefferson A, Wijesurendra RS, McAteer MA, Digby JE, Douglas G, Bannister T et al. Molecular imaging with optical coherence tomography using ligand-conjugated microparticles that detect activated endothelial cells: rational design through target quantification. Atherosclerosis 2011;219:579-87.
88. Xu C, Schmitt JM, Carlier SG, Virmani R. Characterization of atherosclerotic plaques by measuring both backscattering and attenuation coefficients in optical coherence tomography. J Biomed Opt 2008;13:034003.
89. Munce NR, Wright GA, Mariampillai A, Standish BA, Leung MK, Tan L et al. Doppler optical coherence tomography for interventional cardiovascular guidance: in vivo feasibility and forward-viewing probe flow phantom demonstration. J Biomed Opt 2010;15:11103.
90. Liu L, Gardecki JA, Nadkarni SK, Toussaint JD, Yagi Y, Bouma BE et al. Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography. Nat Med 2011;17:1010-4.